Curcumin Blocks Fn-Driven Esophageal Cancer (2026)
Curcumin blocks Fusobacterium nucleatum-driven esophageal squamous cell carcinoma by inhibiting the TLR4/MYD88/TRIF/STAT3 signaling axis, restoring chemotherapy sensitivity in preclinical models.
Bizonyítékszint: Sejtvonalas. Laboratóriumi sejtekben vizsgálták.
Kapcsolódó jelek
- Esophageal Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
- Clinical Trials Update in Resectable Esophageal Cancer
- Advances in targeted therapy for esophageal cancer
- A review of esophageal cancer research: emerging trends, progress and perspectives
- An esophageal cancer clinical trial - ES3